The Time is Ripe for a Randomized Controlled Trial of Oral Vancomycin in Primary Sclerosing Cholangitis

被引：0
|
作者：
Halma, Jennifer Christine [1 ]
Cristoferi, Laura [2 ]
Carbone, Marco [2 ]
机构：
[1] Stanford Univ, Lucile Packard Childrens Hosp, Sch Med, Div Gastroenterol Hepatol & Nutr,Dept Pediat, Stanford, CA 94305 USA
[2] Univ Milano Bicocca, Ctr Autoimmune Liver Dis, Dept Med & Surg, Div Gastroenterol, Monza, Italy
来源：
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2023年 / 21卷 / 10期
关键词：
D O I：
10.1016/j.cgh.2022.11.017
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：2699 / 2700
页数：2
相关论文
共 50 条
  • [41] PROSPECTIVE TRIAL OF PENICILLAMINE IN PRIMARY SCLEROSING CHOLANGITIS
    LARUSSO, NF
    WIESNER, RH
    LUDWIG, J
    MACCARTY, RL
    BEAVER, SJ
    ZINSMEISTER, AR
    GASTROENTEROLOGY, 1988, 95 (04) : 1036 - 1042
  • [42] Oral vancomycin induces sustained deep remission in adult patients with ulcerative colitis and primary sclerosing cholangitis
    de Chambrun, Guillaume Pineton
    Nachury, Maria
    Funakoshi, Natalie
    Gerard, Romain
    Bismuth, Michael
    Valats, Jean-Christophe
    Panaro, Fabrizio
    Navarro, Francis
    Desreumaux, Pierre
    Pariente, Benjamin
    Blanc, Pierre
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (10) : 1247 - 1252
  • [43] Single Center Experience of Oral Vancomycin Therapy in Young Patients with Primary Sclerosing Cholangitis: A Case Series
    Alenchery, Amala J.
    Patel, Sophia
    Mahajan, Lori
    Kurowski, Jacob A.
    Worley, Sarah
    Hupertz, Vera
    Radhakrishnan, Kaddakal
    Kabbany, Mohammad Nasser
    LIVERS, 2023, 3 (01): : 93 - 104
  • [44] Oral Vancomycin Induces and Maintains Remission of Ulcerative Colitis in the Subset of Patients With Associated Primary Sclerosing Cholangitis
    Dao, Alexander
    Abidian, Mohamed
    Lestrange, Aimee
    Mattar, Mark
    Rangnekar, Amol
    Charabaty, Aline
    INFLAMMATORY BOWEL DISEASES, 2019, 25 (07) : E90 - E91
  • [45] Long-term follow-up of a multicenter, randomized controlled trial of ursodeoxycholic acid in primary sclerosing cholangitis
    Hilscher, Moira
    Tabibian, James H.
    Enders, Felicity B.
    Carey, Elizabeth J.
    Lindor, Keith D.
    HEPATOLOGY, 2015, 62 : 509A - 509A
  • [46] Letter to the Editor: Insurance should cover vancomycin for primary sclerosing cholangitis
    Ali, Ahmad H.
    Buness, Cynthia W.
    Fischer, Ryan
    Holtmann, Gerald J.
    Shah, Ayesha
    Lewindon, Peter
    Shah, Shamita
    Ragnekar, Amol S.
    Taylor, Amy E.
    Goel, Aparna
    Cox, Kenneth L.
    Alrabadi, Leina
    Wadsworth, Steve
    Kulkarni, Sakil S.
    Lindor, Keith D.
    HEPATOLOGY, 2023, 77 (06) : E174 - E175
  • [47] Review article: the evidence that vancomycin is a therapeutic option for primary sclerosing cholangitis
    Damman, J. L.
    Rodriguez, E. A.
    Ali, A. H.
    Buness, C. W.
    Cox, K. L.
    Carey, E. J.
    Lindor, K. D.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (07) : 886 - 895
  • [48] Probiotics in primary sclerosing cholangitis: a randomized placebo-controlled crossover pilot study
    Vleggaar, Frank R.
    Monkelbaan, Jan F.
    van Erpecurn, Karel J.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2008, 20 (07) : 688 - 692
  • [49] Effect of Vancomycin on Primary Sclerosing Cholangitis in Patients With Clostridioides difficile Infection
    Yadav, Devvrat
    Pardi, Darrell
    Khanna, Sahil
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S1393 - S1393
  • [50] IMPACT OF VANCOMYCIN ON LIVER FIBROSIS IN PAEDIATRIC PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
    Staudohar, Stefania
    Beedie, Taylor
    Miller, Michael
    Zizzo, Andreanne
    HEPATOLOGY, 2024, 80 : S1858 - S1859
12345